Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal.

Benatar M. et al, (2022), Brain

Creatine kinase and prognosis in amyotrophic lateral sclerosis: a literature review and multi-centre cohort analysis

Gao J. et al, (2022), Journal of Neurology, 269, 5395 - 5404

Comparison Of King’s Clinical Staging In Multinational Amyotrophic Lateral Sclerosis Cohorts

Balendra R. et al, (2022), Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 1 - 11

Modeling seeding and neuroanatomic spread of pathology in amyotrophic lateral sclerosis.

Pandya S. et al, (2022), Neuroimage, 251

The timing of differentiation and potency of CD8 effector function is set by RNA binding proteins.

Petkau G. et al, (2022), Nature communications, 13

A functional screen of RNA binding proteins identifies genes that promote or limit the accumulation of CD138+ plasma cells.

Turner DJ. et al, (2022), eLife, 11

Polypyrimidine Tract Binding Protein 1 regulates the activation of mouse CD8 T cells.

D'Angeli V. et al, (2022), Eur J Immunol

Correction to: ORFLine: a bioinformatic pipeline to prioritize small open reading frames identifies candidate secreted small proteins from lymphocytes.

Hu F. et al, (2022), Bioinformatics (Oxford, England), 38

Genetic testing in motor neurone disease

Dharmadasa T. et al, (2022), Practical Neurology, 22, 107 - 116

Clinical trials in pediatric ALS: a TRICALS feasibility study.

Kliest T. et al, (2022), Amyotroph Lateral Scler Frontotemporal Degener, 1 - 8

Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis

Dreger M. et al, (2022), Journal of Neurology, Neurosurgery & Psychiatry

Diagnosing ALS: the Gold Coast criteria and the role of EMG

Turner MR., (2022), Practical Neurology

Multicentre appraisal of amyotrophic lateral sclerosis biofluid biomarkers shows primacy of blood neurofilament light chain

Thompson AG. et al, (2022), Brain Communications, 4

Pineal gland as the source of the soul and third eye

Savva C. and Turner MR., (2021), Practical Neurology

The RNA-binding protein HuR is required for maintenance of the germinal centre response

Osma-Garcia IC. et al, (2021), Nature Communications, 12

Advancing Mechanistic Understanding and Biomarker Development in Amyotrophic Lateral Sclerosis.

Thompson AG. et al, (2021), Expert Rev Proteomics

Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases.

Benatar M. et al, (2021), Brain

Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis.

Gong C. et al, (2021), Mol Cell, 81, 4059 - 4075.e11

ORFLine: a bioinformatic pipeline to prioritize small open reading frames identifies candidate secreted small proteins from lymphocytes

Hu F. et al, (2021), Bioinformatics, 37, 3152 - 3159

Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis

Thompson AG. et al, (2021), Journal of Neurology, Neurosurgery & Psychiatry

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?